Nipro Corporation (8086.T) stock price, revenue, and financials

Nipro Corporation market cap is ¥166.7 b, and annual revenue was ¥442.52 b in FY 2020

¥166.7 B

8086.T Mkt cap, 27-May-2022

¥341.1 B

Nipro Corporation Revenue Q3, 2021
Nipro Corporation Gross profit (Q3, 2021)105.3 B
Nipro Corporation Gross profit margin (Q3, 2021), %30.9%
Nipro Corporation Net income (Q3, 2021)10.9 B
Nipro Corporation EBIT (Q3, 2021)23.1 B
Nipro Corporation Cash, 31-Dec-2020106 B
Nipro Corporation EV610.8 B
Get notified regarding key financial metrics and revenue changes at Nipro CorporationLearn more
Banner background

Nipro Corporation Revenue

Nipro Corporation revenue was ¥442.52 b in FY, 2020 which is a 3.8% year over year increase from the previous period.

Embed Graph

Nipro Corporation Revenue Breakdown

Embed Graph

Nipro Corporation revenue breakdown by business segment: 8.2% from PharmaPackaging, 15.9% from Pharmaceutical-Related, 75.9% from Medical-Related and 0.0% from Other

Nipro Corporation revenue breakdown by geographic segment: 13.5% from Asia, 60.5% from Japan, 11.5% from Europe and 14.5% from Americas

Nipro Corporation Income Statement

Annual

JPYFY, 2018FY, 2019FY, 2020

Revenue

395.4b426.4b442.5b

Revenue growth, %

8%4%

Cost of goods sold

268.3b295.8b308.3b

Gross profit

127.1b130.6b134.2b

Gross profit Margin, %

32%31%30%

General and administrative expense

100.0b106.8b107.8b

Operating expense total

100.0b106.1b107.8b

EBIT

27.1b23.8b26.4b

EBIT margin, %

7%6%6%

Interest expense

3.5b3.3b3.5b

Interest income

577.0m816.0m847.0m

Pre tax profit

17.0b21.2b(10.2b)

Income tax expense

4.7b9.4b1.4b

Net Income

12.3b11.9b(11.6b)

EPS

64.566.7

Nipro Corporation Balance Sheet

Annual

JPYFY, 2018FY, 2019FY, 2020

Cash

141.9b129.4b95.9b

Accounts Receivable

140.5b149.0b152.5b

Inventories

129.2b137.9b153.3b

Current Assets

436.0b443.0b433.0b

PP&E

270.3b284.5b307.6b

Goodwill

27.4b19.3b14.7b

Total Assets

826.8b845.8b831.9b

Accounts Payable

62.1b69.6b69.5b

Short-term debt

130.1b144.6b165.1b

Current Liabilities

251.2b274.3b289.4b

Long-term debt

380.5b385.5b360.5b

Non-Current Liabilities

392.1b399.7b381.2b

Total Debt

510.6b530.1b525.6b

Total Liabilities

643.3b674.0b670.6b

Common Stock

84.4b84.4b84.4b

Additional Paid-in Capital

5.0m

Retained Earnings

83.6b90.7b74.8b

Total Equity

183.5b171.8b161.3b

Debt to Equity Ratio

2.8 x3.1 x3.3 x

Debt to Assets Ratio

0.6 x0.6 x0.6 x

Financial Leverage

4.5 x4.9 x5.2 x

Nipro Corporation Cash Flow

Annual

JPYFY, 2018FY, 2019FY, 2020

Net Income

12.3b11.9b(11.6b)

Depreciation and Amortization

38.2b39.5b47.5b

Accounts Receivable

(7.3b)(12.3b)(2.7b)

Inventories

(4.9b)(11.4b)(15.2b)

Accounts Payable

(3.8b)11.8b205.0m

Cash From Operating Activities

41.0b41.4b37.2b

Purchases of PP&E

(60.1b)(56.0b)(57.9b)

Cash From Investing Activities

(64.1b)(64.7b)(58.3b)

Short-term Borrowings

8.8b(6.7b)18.6b

Long-term Borrowings

(91.2b)(70.9b)(102.4b)

Dividends Paid

(6.5b)(5.0b)(3.8b)

Cash From Financing Activities

47.3b12.6b(4.6b)

Net Change in Cash

23.6b(15.4b)(30.2b)

Interest Paid

3.3b3.2b3.2b

Income Taxes Paid

7.3b8.2b9.1b

Half Year

JPYH1, 2019H1, 2020H1, 2021

Net Income

7.7b6.2b5.8b

Depreciation and Amortization

18.2b19.8b19.8b

Accounts Receivable

(5.9b)(3.2b)(743.0m)

Inventories

(3.3b)(6.8b)(10.2b)

Accounts Payable

5.8b(173.0m)2.4b

Cash From Operating Activities

19.7b15.3b23.2b

Purchases of PP&E

(33.1b)(30.6b)(24.2b)

Cash From Investing Activities

(37.6b)(35.2b)(22.2b)

Short-term Borrowings

(5.5b)16.5b(10.9b)

Long-term Borrowings

(34.4b)(56.1b)(32.6b)

Dividends Paid

(1.9b)(1.5b)(53.0m)

Cash From Financing Activities

20.2b(2.3b)29.6b

Net Change in Cash

383.0m(24.5b)25.1b

Interest Paid

1.4b1.7b1.9b

Income Taxes Paid

4.3b4.8b4.0b

Nipro Corporation Ratios

JPYFY, 2018

Revenue/Employee

14.0m

Debt/Equity

2.8 x

Debt/Assets

0.6 x

Financial Leverage

4.5 x

Nipro Corporation Operating Metrics

Y, 2018Y, 2019Y, 2020

Ampoules/Vials Produced

700 m700 m

Capsules Produced

400 m400 m400 m

Dual Chamber Bags Produced

33 m33 m33 m

Granules/ Dry Syrups Produced, tons

610610

Liquid-Liquid Dual Chamber Bags Produced

4 m4 m

Ointments/Creams Produced, 10g-tubes

16.3 m16.3 m

Poultices Produced, 10g-sheets

390 m390 m390 m

Pre-filled Syringes Produced

160 m160 m160 m

Syrups Produced, bottles

460 k460 k

Tablets Produced

14 b14.8 b14.8 b

Tapes Produced (Hotmelt Type), sheets

150 m580 m580 m

Tapes Produced (Solvent Type), sheets

120 m120 m

Nipro Corporation Employee Rating

3.674 votes
Culture & Values
2.5
Work/Life Balance
2.8
Senior Management
2.7
Salary & Benefits
3
Career Opportunities
2.5
Source